Key Trends Influencing the Growth of the Radiotherapy Devices Market in 2025: Artificial Intelligence (AI) Revolutionizes Radiotherapy Devices Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Radiotherapy Devices Market Through 2025?
Over the past few years, the market size for radiotherapy devices has experienced robust growth. Expected to rise from $6.13 billion in 2024 to $6.71 billion in 2025, the market will see a compound annual growth rate (CAGR) of 9.5%. Causes for this historic growth include an increase in cancer cases, the focus on patient-centric care, an aging population, heightened awareness about radiotherapy devices, and advancements in teletherapy and remote monitoring.

What's the Projected Size of the Global Radiotherapy Devices Market by 2029?
Expectations are high for robust growth in the radiotherapy devices market in the coming years, with predictions that the market will reach a value of $9.73 billion in 2029, growing at a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this anticipated growth include the expansion of proton therapy, the combination of immunotherapy, the introduction of remote monitoring and teletherapy, and an increasing demand for precise, targeted radiation treatments and minimally invasive radiotherapy techniques. Noteworthy trends predicted for the forecast period are advancements in proton therapy, the rise of hypofractionated and adaptive radiotherapy, improved patient experiences, and the integration of artificial intelligence (AI).

View the full report here:
https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Top Growth Drivers in the Radiotherapy Devices Industry: What's Accelerating the Market?
The surge in cancer cases is anticipated to fuel the expansion of the market for radiotherapy devices. Cancer prevalence denotes the sum or proportion of individuals in a community who have been detected with cancer at a specific timeframe or over a particular period. Radiotherapy is widely used as a primary or supplementary treatment for newly diagnosed cancer patients. It is generally used to reduce tumors, control the advancement of cancer, or eradicate cancer cells prior to or following surgery. For example, statistics from the Australian Institute of Health and Welfare, an Australian government agency, disclosed that there was a considerable increase in cancer diagnoses in Australia, going up from 160,570 cases in 2022 to 164,694 cases in 2023. This upward trajectory underscores the escalating prevalence of cancer in the country. Consequently, the surging prevalence of cancer is facilitating the growth of the radiotherapy devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3375&type=smp

What Trends Will Shape the Radiotherapy Devices Market Through 2029 and Beyond?
AI reigns as a predominant trend in the radiotherapy device market, bolstering its reputation increasingly. The integration of AI technology into disease treatment is anticipated to enhance diagnostic precision and pace, aid medical decision-making, and ultimately yield superior results. For instance, in October 2022, HCG cancer hospital introduced an AI-driven radiation therapy technology to optimize radiotherapy. Whilst the conventional treatment planning process can take days to build an optimal plan, the advent of AI technology is accelerating this process. Furthermore, AI is likely to extend to deep learning applications in treatment planning, clinical decision support, automated image-guided adaptive radiation therapy, and genomic/radio-biologic data analysis, which in turn promotes market growth.

What Are the Main Segments in the Radiotherapy Devices Market?
The radiotherapy devices market covered in this report is segmented -

1) By Product Type: External Beam Radiation Therapy Devices, Linear Accelerator Devices, Proton Therapy Devices
2) By Application: Skin Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Other Applications
3) By End Users: Hospitals, Ambulatory Surgical Centers, Oncological Treatment Centers

Subsegments:
1) By External Beam Radiation Therapy Devices: Intensity-Modulated Radiation Therapy (IMRT) Devices, Image-Guided Radiation Therapy (IGRT) Devices, Stereotactic Body Radiation Therapy (SBRT) Devices, Stereotactic Radiosurgery (SRS) Devices, 3D Conformal Radiation Therapy (3D CRT) Devices
2) By Linear Accelerator Devices: Conventional Linear Accelerators, Stereotactic Linear Accelerators
3) By Proton Therapy Devices: Cyclotron-Based Devices, Synchrotron-Based Devices, Synchrocyclotron-Based Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3375&type=smp

Which Top Companies are Driving Growth in the Radiotherapy Devices Market?
Major companies operating in the radiotherapy devices market include Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Becton inson and Company, IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Eckert & Ziegler Bebig, IsoRay Inc., General Electric Healare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corporation, Canon Medical Systems Corporation, AngioDynamics Inc., Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co. Ltd., Mevion Medical Systems Inc., Optivus Proton Therapy Inc., Panacea Medical Technologies Pvt. Ltd., P-Cure Ltd., Provision Healare LLC, Sumitomo Heavy Industries Ltd., ViewRay Inc., Miranda Medical, Nordion Inc., NTP Radioisotopes SOC Ltd., Curium, Hitachi Ltd., Brainlab AG, Best Theratronics Ltd., ProTom International Inc., RefleXion Medical Inc., Insightec Ltd., HistoSonics Inc., Novocure Ltd., TomoTherapy Incorporated, Agile MV LLC, CIVCO Radiotherapy, Neutron Therapeutics, Diapulse Corporation of America, Johari Digital Healare Ltd., Alpha Tau Medical Ltd.

Which Regions Will Dominate the Radiotherapy Devices Market Through 2029?
North America was the largest region in the radiotherapy devices market in 2023. Asia-Pacific was the second-largest region in the global radiotherapy devices market report. The regions covered in the radiotherapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3375

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.